FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/04/041654 [Registered on: 05/04/2022] Trial Registered Prospectively
Last Modified On: 06/04/2022
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   To evaluate macular and peripapillary microvascular changes in systemic hypertension as measured by optical coherence tomography angiography technology 
Scientific Title of Study   Evaluation of macular and peripapillary microvascular changes in systemic hypertension as measured by optical coherence tomography angiography 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Yashi Gupta 
Designation  Post graduate trainee 
Affiliation  Maulana Azad Medical college and Associated Guru Nanak Eye Centre, New Delhi 
Address  Room No. 221,Department of Ophthalmology, Guru Nanak Eye Centre, Maharaja ranjit singh marg, New Delhi- 110002

New Delhi
DELHI
110002
India 
Phone  9873976836  
Fax    
Email  yaasshi12@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Meenakshi Thakar 
Designation  Director Professor 
Affiliation  Maulana Azad Medical college and Associated Guru Nanak Eye Centre, New Delhi 
Address  Room No. 221,Department of Ophthalmology, Guru Nanak Eye Centre, Maharaja ranjit singh marg, New Delhi- 110002

New Delhi
DELHI
110002
India 
Phone  9873976836  
Fax    
Email  meenakshithakar147@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Yashi Gupta 
Designation  Post graduate trainee 
Affiliation  Maulana Azad Medical college and Associated Guru Nanak Eye Centre, New Delhi 
Address  Room No. 221,Department of Ophthalmology, Guru Nanak Eye Centre, Maharaja ranjit singh marg, New Delhi- 110002

New Delhi
DELHI
110002
India 
Phone  9873976836  
Fax    
Email  yaasshi12@gmail.com  
 
Source of Monetary or Material Support  
Maulana Azad Medical College And Associated Guru Nanak Eye Centre, New Delhi 110002 
 
Primary Sponsor
Modification(s)  
Name  Department of Ophthalmology 
Address  Room No. 221,Department of Ophthalmology, Guru Nanak Eye Centre, Maharaja ranjit singh marg, New Delhi- 110002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Yashi Gupta  Guru Nanak Eye Centre  Room No. 221,Department of Ophthalmology, Guru Nanak Eye Centre, Maharaja ranjit singh marg, New Delhi- 110002
New Delhi
DELHI 
9873976836

yaasshi12@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H350||Background retinopathy and retinalvascular changes,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Hypertensive patients on medication for more than 5 years
2.Age: 30-60 years
3.BCVA ≥ 6/12
 
 
ExclusionCriteria 
Details  1.Significant ocular media opacity (in order to maximize good quality images)
2.Grade 3 hypertensive retinopathy and above (according to Keith Wagener Barker classification).
3.Any other ocular pathology, e.g. macular edema, diabetic retinopathy, optic nerve disorders etc.
4.Any intraocular surgery
5.Any other systemic illness.
6.Refractive errors (> +3 D, axial length (AL) >26.0 mm)
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1-To measure Macular and peripapillary OCTA parameters (VD, PD and FAZ dimensions) in systemic hypertension vs control group.  Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
1) Measurement of structural OCT Parameters (CMT, GC-IPL and RNFL thicknesses)
in systemic hypertension vs normal control group.
 
Baseline 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/04/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study aims at evaluating changes occurring in the microvasculature of the retina primarily evaluated at the macular and peripapillary region through oct angiography in hypertensive patients in comparison to the normal control group. The study aims at picking up subtle signs of microvascular damage as measured by oct and octa technology well before clinical signs of hypertension manifest in the body. 
Close